Bacterial Toxins: Methods and Protocols pp 241-257 | Cite as
T-Cell Cytotoxicity Assays for Studying the Functional Interaction Between the Superantigen Staphylococcal Enterotoxin A and T-Cell Receptors
- 1 Citations
- 1.3k Downloads
Abstract
The superantigens (SAgs) staphylococcal enterotoxins (SEs) are produced by certain strains of Staphylococcus aureus and comprise structurally related bacterial proteins, which are among the most potent mitogens known for murine and human T lymphocytes (1,2). T-cell activation induced by SEs involves binding to constant parts of major histocompatibility complex (MHC) class II molecules and subsequent interaction with T cells expressing certain T-cell receptor (TCR) Vβ chains (3,4). The binding of SAgs to MHC class II molecules does not require processing and structural mutations, and biochemical experiments have demonstrated that the amino acids involved are distant from the antigen binding groove.
Keywords
Major Histocompatibility Complex Class Effector Cell Staphylococcal Enterotoxin Background Release Cell Dissociation SolutionReferences
- 1.Marrack P. and Kappler J. (1990) The staphylococcal enterotoxins and their relatives [published erratum appears in Science 1990 1;248(4959): 1066]. Science 248. 705–711.PubMedCrossRefGoogle Scholar
- 2.Betley M. J., Borst D. W., and Regassa L. B. (1992) Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem. Immunol. 55 1–35.PubMedCrossRefGoogle Scholar
- 3.Fraser J. D. (1989) High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339, 221–223.PubMedCrossRefGoogle Scholar
- 4.Fischer H., Dohlsten M., Lindvall M., Sjogren H. O., and Carlsson R. (1989) Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J. Immunol. 142, 3151–3157.PubMedGoogle Scholar
- 5.Fischer H., Dohlsten M., Andersson U., Hedlund G., Ericsson P., Hansson J., and Sjogren H. O. (1990) Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells. J. Immunol. 144, 4663–4669.PubMedGoogle Scholar
- 6.Carlsson R. and Sjogren H. O. (1985) Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell Immunol. 96.175–183.PubMedCrossRefGoogle Scholar
- 7.Dohlsten M., Bjorklund M., Sundstedt A., Hedlund G., Samson D., and Kalland T. (1993) Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Immunology 79, 520–527.PubMedGoogle Scholar
- 8.Rosendahl A., Hansson J., Antonsson P., Sekaly R. P., Kalland T., and Dohlsten M. (1997) A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor V beta repertoire in vivo. Infect Immun. 65, 5118–5124.PubMedGoogle Scholar
- 9.Janeway C. A., Jr., Yagi J., Conrad P. J., Katz M. E., Jones B., Vroegop S., and Buxser S. (1989) T-cell responses to Mis and to bacterial proteins that mimic its behavior. Immunol. Rev. 107, 61–88.PubMedCrossRefGoogle Scholar
- 10.Scherer M. T., Ignatowicz L., Winslow G. M., Kappler J. W., and Marrack P. (1993) Super antigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell. Biol. 9, 101–128.PubMedCrossRefGoogle Scholar
- 11.Kotzin B. L., Leung D. Y., Kappler J., and Marrack P. (1993) Superantigens and their potential role in human disease. Adv. Immunol. 54, 99–166.PubMedCrossRefGoogle Scholar
- 12.Kappler J. W., Staerz U., White J., and Marrack P. C. (1988) Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompat-ibility complex. Nature 332, 35–40.PubMedCrossRefGoogle Scholar
- 13.Dustin M. L. and Springer T. A. (1989) T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341, 619–624.PubMedCrossRefGoogle Scholar
- 14.Sundstedt A., Hoiden I, Hansson J., Hedlund G., Kalland T., and Dohlsten M. (1995) Superantigen-induced anergy in cytotoxic CD8+ T cells. J. Immunol. 154. 6306–6313.PubMedGoogle Scholar
- 15.Scholz M., Cinatl J., Gross V., Vogel J. U., Blaheta R. A., Freisleben H. J., Markus B. H., and Doerr B. H. (1996) Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Transplantation 61, 1763–1770.PubMedCrossRefGoogle Scholar
- 16.Viac J., Schmitt D., and Claudy A. (1994) Adhesion molecules and inflammatory dermatoses. Allerg. Immunol. Paris 26, 274–277.Google Scholar
- 17.Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K. J., Podack E.R., Zinkernagel R. M., and Hengartner H. (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perfor in-deficient mice. Nature 369, 31–37.PubMedCrossRefGoogle Scholar
- 18.Podack E. R. and Kupfer A. (1991) T-cell effector functions: mechanisms for delivery of cytotoxicity and help. Annu. Rev. Cell Biol. 7, 479–504.PubMedCrossRefGoogle Scholar
- 19.Podack E. R., Young J. D., and Cohn Z. A. (1985) Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc.Natl. Acad. Sci. USA 82, 8629–8633.PubMedCrossRefGoogle Scholar
- 20.Rosendahl A., Kristensson K., Hansson J., Riesbeck K., Kalland T., and Dohlsten M. (1998) Perforin andlFN-yare involved in the anti-tumor effects of antibody targeted superantigens. J. Immunol. 160, 5309–5313.PubMedGoogle Scholar